Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Window in Pediatric B-NHL/B-ALL
NCT00324779Phase 2Completed
- Sponsor
- University Hospital Erlangen
- Start
- Mar 2004
- Primary completion
- Apr 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab in non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL), sponsored by University Hospital Erlangen. Started Mar 2004; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00324779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324779.